1.
Molinaro S, Gambalunga F, Bolgeo T, et al. Adherence to Oral Molecular Targeted Therapy in Metastatic Renal Cell Carcinoma: A Qualitative Study. IJHS. 2026;1(Suppl. 2):262–263. Accessed November 1, 2026. https://journals.ieditore.com/index.php/IJHS/article/view/631